199 related articles for article (PubMed ID: 17883396)
1. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers.
Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F
J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396
[TBL] [Abstract][Full Text] [Related]
2. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
Schnack C; Danzer KM; Hengerer B; Gillardon F
Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
[TBL] [Abstract][Full Text] [Related]
3. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
4. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
[TBL] [Abstract][Full Text] [Related]
6. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
Frasier M; Walzer M; McCarthy L; Magnuson D; Lee JM; Haas C; Kahle P; Wolozin B
Exp Neurol; 2005 Apr; 192(2):274-87. PubMed ID: 15755545
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
[TBL] [Abstract][Full Text] [Related]
8. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
Emmanouilidou E; Stefanis L; Vekrellis K
Neurobiol Aging; 2010 Jun; 31(6):953-68. PubMed ID: 18715677
[TBL] [Abstract][Full Text] [Related]
9. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression.
Fan Y; Limprasert P; Murray IV; Smith AC; Lee VM; Trojanowski JQ; Sopher BL; La Spada AR
Hum Mol Genet; 2006 Oct; 15(20):3002-11. PubMed ID: 16959793
[TBL] [Abstract][Full Text] [Related]
10. Endogenous catecholamine enhances the dysfunction of unfolded protein response and alpha-synuclein oligomerization in PC12 cells overexpressing human alpha-synuclein.
Ito S; Nakaso K; Imamura K; Takeshima T; Nakashima K
Neurosci Res; 2010 Jan; 66(1):124-30. PubMed ID: 19835916
[TBL] [Abstract][Full Text] [Related]
11. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
[TBL] [Abstract][Full Text] [Related]
12. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P
Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637
[TBL] [Abstract][Full Text] [Related]
13. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
16. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
[TBL] [Abstract][Full Text] [Related]
17. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.
Thomas MP; Chartrand K; Reynolds A; Vitvitsky V; Banerjee R; Gendelman HE
J Neurochem; 2007 Jan; 100(2):503-19. PubMed ID: 17241161
[TBL] [Abstract][Full Text] [Related]
18. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
19. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein.
Lee HJ; Khoshaghideh F; Lee S; Lee SJ
Eur J Neurosci; 2006 Dec; 24(11):3153-62. PubMed ID: 17156376
[TBL] [Abstract][Full Text] [Related]
20. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
Kahle PJ
Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
